Alexander J Muller

5PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 30, 2025
Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness.

|Dec 30, 2021
The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism.

Lauren M F Merlo, Weidan Peng, James B DuHadaway

|Feb 24, 2021
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization.

Souvik Dey, Arpita Mondal, James B DuHadaway

|Jul 22, 2020
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses.

Souvik Dey, Erika Sutanto-Ward, Katharina L Kopp

|Sep 30, 2018
Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers.

Avinoam Nevler, Alexander J Muller, Erika Sutanto-Ward

Pageof 1

Frequent Collaborators

2 joint publications

George C Prendergast

2 joint publications

James B DuHadaway

2 joint publications

Laura Mandik-Nayak

1 joint publications

Avinoam Nevler